Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason T Huse

Showing results (141-150 of 188) with videos related to

Pageof 19
Sort By:
Biorxiv : the Preprint Server for Biology|May 18, 2026
Deciphering the Genomic Landscape of Renal Cell Carcinoma Brain MetastasesBetul Gok Yavuz, Peng Li, Jose A Ovando-Ricardez, et al.
The Lancet. Oncology|November 3, 2023
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groupsPhilipp Karschnia, Marion Smits, Guido Reifenberger, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
Recurrent <i>ERBB2</i> alterations are associated with esophageal adenocarcinoma brain metastasesNora M Lawson, Lingqun Ye, Chae Yun Cho, et al.
Oncoimmunology|October 25, 2019
Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumorsIoannis Kaffes, Frank Szulzewsky, Zhihong Chen, et al.
JCI Insight|July 30, 2020
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restorationMartina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.
Brain Pathology (Zurich, Switzerland)|May 6, 2025
Comparative pathology boards facilitate the translation of knowledge between canine and human cancer patientsJessica A Beck, Christina Mazcko, Sara Belluco, et al.
JAMA Oncology|December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A ReviewCraig Horbinski, David A Solomon, Rimas V Lukas, et al.
Nature Communications|July 10, 2021
Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosineYasaman Barekatain, Jeffrey J Ackroyd, Victoria C Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II TrialShiao-Pei Weathers, Marta Penas-Prado, Be-Lian Pei, et al.
Cell Reports|January 12, 2022
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitizationTingting Qin, Brendan Mullan, Ramya Ravindran, et al.
Pageof 19

Showing results (141-150 of 188) with videos related to

Sort By:
Pageof 19
Biorxiv : the Preprint Server for Biology|May 18, 2026
Deciphering the Genomic Landscape of Renal Cell Carcinoma Brain MetastasesBetul Gok Yavuz, Peng Li, Jose A Ovando-Ricardez, et al.
The Lancet. Oncology|November 3, 2023
A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groupsPhilipp Karschnia, Marion Smits, Guido Reifenberger, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
Recurrent <i>ERBB2</i> alterations are associated with esophageal adenocarcinoma brain metastasesNora M Lawson, Lingqun Ye, Chae Yun Cho, et al.
Oncoimmunology|October 25, 2019
Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumorsIoannis Kaffes, Frank Szulzewsky, Zhihong Chen, et al.
JCI Insight|July 30, 2020
Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restorationMartina Ott, Karl-Heinz Tomaszowski, Anantha Marisetty, et al.
Brain Pathology (Zurich, Switzerland)|May 6, 2025
Comparative pathology boards facilitate the translation of knowledge between canine and human cancer patientsJessica A Beck, Christina Mazcko, Sara Belluco, et al.
JAMA Oncology|December 26, 2024
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors: A ReviewCraig Horbinski, David A Solomon, Rimas V Lukas, et al.
Nature Communications|July 10, 2021
Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosineYasaman Barekatain, Jeffrey J Ackroyd, Victoria C Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2020
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II TrialShiao-Pei Weathers, Marta Penas-Prado, Be-Lian Pei, et al.
Cell Reports|January 12, 2022
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitizationTingting Qin, Brendan Mullan, Ramya Ravindran, et al.
Pageof 19